Grünenthal Mexico – Tomás Bordonaba, Managing Director
Latin America continues to be in the spotlight at Grünenthal. The managing director for Mexico explains how the…
Grünenthal is an independent multinational pharmaceutical company dedicated to research. Since its founding in 1946 until today it has been a family business. Grünenthal and its products are represented in over 100 countries and the number of branches increases continuously. Grünenthal has, globally, around 5,300 employees who are key to the success of the company. Innovative research is an important factor of our company policy to secure the future. Grünenthal has the ambition to belong to the leading companies in research and development in selected therapeutic areas: pain is our central field. In 1998 Grünenthal formally started operations in Mexico and focusing on the therapeutic areas of ‘pain relief’, gynecological infections and treatments, offering to physicians and their patients products and services of the highest quality.
Periférico Sur 5991
Col. Arenal Tepepan, Del. Tlalpan
CP 14610 México DF
MÉXICO
www.grunenthal.com
Latin America continues to be in the spotlight at Grünenthal. The managing director for Mexico explains how the…
Grünenthal first started operations in Mexico back in 1998, we then interviewed Mr. Klaus Kuchen in 2005, but…
Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational…
The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…
Pfizer, one of the world’s largest pharmaceutical companies, has been active in Mexico since 1951, and has been…
Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking…
Biogen Mexico’s Luis Calderon discusses establishing the affiliate, the opportunities apparent in the Mexican…
A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from…
UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas…
Americo Garcia oversees Latin American operations for Canadian generics player Apotex. He outlines the firm’s…
Inosan Biopharma General Manager Juan Lopez de Silanes outlines the Mexican family company’s recent milestones,…
Sara Montero, managing director of Lundbeck Mexico, Central America and Andean countries since January 2020,…
Mauricio Guizar, newly appointed general manager of Ipsen Mexico since October 2019, shares his first impression of…